In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Glaxo, SmithKline merge

Executive Summary

SmithKline Beecham and Glaxo Wellcome are merging, creating Glaxo SmithKline, a company with annual sales of $25bn, a market cap of $189bn, and 40k employees. Glaxo shareholders will own 58.75% of the new company. The transaction is expected to close this summer, and values SB at $78bn.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies